SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2433You set a record for patience if you still hold them! I remember you talking aborkrw-7/11/2007
2432NBSC finally goes, to Eppendorf. $11.50/share. (eom)scaram(o)uche-7/11/2007
24312:24AM Noven Pharma to acquire JDS Pharmaceuticals (NOVN) 23.55 : Co announces tIan@SI-7/10/2007
2430Ventana BOD said they would advise shareholders within 10 business days. That wtuck-7/10/2007
2429>>Law May Derail Roche Bid for Ventana Friday July 6, 6:02 am ET By Christuck-7/6/2007
2428Possible target: Cepheid (CPHD) >>Out of the Gate: Cepheid Peaks Thursdatuck-7/5/2007
2427That's the dilemma for a company the size of Lundbeck. They're not reallnigel bates-7/4/2007
2426Perhaps they'll go all the way past depression and buy ACAD. <G>Ian@SI-7/4/2007
2425Lundbeck want something significant (in CNS) - reuters.com "...Lundbeck cnigel bates-7/4/2007
2424:-)DewDiligence_on_SI-7/3/2007
2423>>I thought this board was for mergers and acquisitions that have already tuck-7/3/2007
2422I thought this board was for mergers and acquisitions that have already been annDewDiligence_on_SI-7/3/2007
2421Bristol-Myers tasty bite for pharma companies The market cap of the company is crichardred-7/3/2007
2420biz.yahoo.comrichardred-7/3/2007
2419There was an article (in yesterday's WSJ, I think) that looked at the valuattom pope-6/27/2007
2418Since VMSI is trading above the offer, it is apparent the Street believes there tuck-6/27/2007
2417Roche's Hostile Bid for Ventana Would Boost Diagnostic Portfolio By ANITA GDoc Bones-6/27/2007
24164:00PM Ventana Medical: Roche makes offer to acquire Ventana for $75.00 per sharIan@SI-6/25/2007
24159/11 whores.... the sector never made it back. Not saying that there's ascaram(o)uche-6/20/2007
2414>> Privately-held << Yes, it's beginning to get irritating.nigel bates-6/20/2007
2413>> Privately-held << Shucks, I guess they don't have boring in-scaram(o)uche-6/19/2007
2412Roche agrees to buy NimbleGen for $272.5 mln By Sam Cage ZURICH, June 19 (Reutenigel bates-6/19/2007
2411Makes one wonder a bit more about the Tularik munch. T131 for diabetes was in Ptuck-6/6/2007
2410Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Camnigel bates-6/6/2007
2409Amgen to Acquire Ilypsa, a Private San Francisco Bay Area Biotechnology Company scaram(o)uche-6/4/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News